Aarti Drugs Multibagger Stock Return 3:1 Bonus Issue

Aarti Drugs Ltd established in the year 1984 is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and forms part of $900 Million Aarti Group of Industries. For the period Mar20 the company had an ROE of 23.65%, ROCE of 21.39% and a gross profit margin of 32.93 % valuation-wise the company trades at TTMP/E of 38.78.

The returns that the company has provided this year has been phenomenal. The average return YTD is 19.87% and the returns for the last three months have been 30.71%. The company also announced a 3:1 bonus in the month of September and has been hitting the upper circuit of 5% for the last three trading sessions.

With strong earnings expected for the entire Pharma Sector, Aarti Drugs is well placed to create wealth for its shareholders. Buy Aarti Drugs for a 30% return in the next 9-12 months


Hi i am Samiran Debnath Admin of this website. I am Financial Advisor by profession build client portfolio in stock market and Mutual Fund. I help people to dematerilise physical shares into electronic mode opening demat account. Help clients to choose best insurance policy for them. I love sharing my views on stock market and the benefits investing in SIP and Mutual Funds.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

4 × 1 =